Does Rallies show 13F holders for CI?

Yes. Rallies tracks hedge fund and 13F ownership data for CI, including fund names, share counts, latest tracked quarter, and position changes when available.

Is CI research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CI. It does not provide personalized investment advice.

CI (Cigna) Stock Analysis - Hedge Fund Holdings

Cigna (CI) is a publicly traded Financial Services sector company. As of May 20, 2026, CI trades at $283.41 with a market cap of $75.84B and a P/E ratio of 12.72. CI moved -2.69% today. Year to date, CI is +4.36%; over the trailing twelve months it is -9.53%. Its 52-week range spans $239.51 to $358.88. Analyst consensus is strong buy with an average price target of $341.93. Rallies surfaces CI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns CI stock?

Hedge funds tracked by Rallies that own CI include GQG Partners, Glenview Capital, Cooperman Leon, Bridgewater Associates, and Orbimed Advisors. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Cigna.

CI Key Metrics

Key financial metrics for CI
Metric	Value
Price	$283.41
Market Cap	$75.84B
P/E Ratio	12.72
EPS	$22.33
Dividend Yield	1.56%
52-Week High	$358.88
52-Week Low	$239.51
Volume	879.39K
Avg Volume	0
Revenue (TTM)	$274.90B
Net Income	$6.29B
Gross Margin	21.79%

Top Hedge Funds Holding CI

GQG Partners holds 6.00M shares of CI, changed -22.68% as of Mar 31, 2026.
Glenview Capital holds 498.84K shares of CI, changed +78.56% as of Mar 31, 2026.
Cooperman Leon holds 325.00K shares of CI, changed +0.00% as of Mar 31, 2026.
Bridgewater Associates holds 228.49K shares of CI, changed -33.66% as of Mar 31, 2026.
Orbimed Advisors holds 205.00K shares of CI, changed +25.92% as of Dec 31, 2025.

Latest CI News

Cigna jumps as Q1 results beat and 2026 adjusted EPS outlook raised — May 6, 2026
Cigna Exits Obamacare Marketplace; Q1 EPS Beats as PBM Income Falls 28% — Apr 30, 2026
Cigna Raises 2026 Outlook After Q1 Revenues Climb 5% to $68.5B — Apr 30, 2026
Cigna jumps 3% as traders position ahead of April 30 earnings report — Apr 27, 2026
Cigna to Standardize Electronic Prior Authorization for Over 70% of Volume — Apr 24, 2026

Recent CI Insider Trades

Cordani David sold 3.90K (~$1.12M) on May 12, 2026.
Cordani David sold 14.29K (~$4.12M) on May 12, 2026.
Cordani David sold 13.84K (~$4.00M) on May 12, 2026.

CI Analyst Consensus

17 analysts cover CI: 0 strong buy, 16 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $341.93.

Common questions about CI

Who owns CI stock?: Hedge funds tracked by Rallies that own CI include GQG Partners, Glenview Capital, Cooperman Leon, Bridgewater Associates, and Orbimed Advisors. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Cigna.
Does Rallies show 13F holders for CI?: Yes. Rallies tracks hedge fund and 13F ownership data for CI, including fund names, share counts, latest tracked quarter, and position changes when available.
Is CI research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CI. It does not provide personalized investment advice.